May 9, 2023
Nerivio is a neuromodulation device that has been approved for the acute and preventative treatment of migraine for people aged 12 years and older. But how does it work? Who can use it? Tune in as we answer these questions and more with the CEO and co-founder Alon Ironi!
*The contents of this podcast are intended for...
Apr 11, 2023
What is allodynia, and why does it happen? In this episode, Dr. Gretchen Tietjen answers these questions and more, diving into the nuances of this symptom that is often associated with migraine.
*The contents of this podcast are intended for general informational purposes only and does not constitute...
Mar 7, 2023
Atogepant is FDA approved for the prevention of episodic migraine, and is under review for the prevention of chronic migraine at the time of publication. Stay tuned as Dr. Cynthia E. Armand discusses the goals of migraine prevention, atogepant clinical trial data, how it compares to other gepant medications, side...
Feb 15, 2023
How are patent foramen ovale and migraine connected? A foramen ovale is a "hole" between the top two chambers of the heart. This hole closes shortly after birth, but in some individuals it stays open and is known as patent foramen ovale. Studies show that adults with this cardiovascular condition are more likely to...
Jan 24, 2023
Hear from Dr. Eric Pearlman, Associate Vice President at Eli Lilly, as we dive into their findings from the OVERCOME study. This study aims to further understand the stigma experienced by people living with migraine, identify barriers to the appropriate treatment, and assess how novel treatment options may...